Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court jury decided on Wednesday.
A panel of advisers to the U.S. Food and Drug Administration on Wednesday recommended against authorizing Veru Inc's oral COVID-19 pill for treating moderate-to-severe hospitalized patients at high risk for developing acute respiratory distress syndrome.
An investment by NB Renaissance in Neopharmed that will see the private equity firm share with Ardian majority ownership of the Italian pharmaceutical group values the latter at 1.4-1.5 billion euros ($1.4-$1.5 billion), two people close to the deal said.
Britain's health regulator on Wednesday approved the country's first two-pronged COVID-19 booster targeting the Omicron BA.4 and BA.5 sub-variants and the original coronavirus strain.
Much of the global pharmaceutical and biotech industry has yet to set any targets for reducing carbon emissions in line with the Paris Agreement, a new analysis has found, despite the biggest companies in the sector leading the way.
Voters in five states weighed in on abortion-related ballot measures, initiatives that have taken on new urgency since the U.S. Supreme Court in June overturned the Roe v. Wade decision that had legalized abortion nationwide.
Chinese pharmaceutical company CanSino Biologics said on Wednesday its inhalable COVID-19 vaccines will be available in China's northern city of Tianjin from Nov 10, a statement on its Wechat account said.
U.S. drugmaker Clovis Oncology said on Wednesday it was likely to file for bankruptcy "in the very near term", as the company struggles to sell its cancer drug Rubraca.
More than three quarters of British people who have suffered persistent ill health following a COVID-19 infection have had to cut back or change the work they do, according to a survey on the impact of long COVID published on Wednesday.
Millions of residents of China's southern manufacturing hub of Guangzhou were told on Wednesday to get tested for COVID-19, as infections topped two thousand for two days running in the city's worst outbreak so far.
